Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical device regulation, and what we’re reading from around the web. This week, ...

That panel will meet to weigh whether the agency should allow Americans to have broader access to seven injectable peptides ...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and ...

Hours after Taco Bell said it is voluntarily pulling lettuce from its entire U.S. supply chain, the FDA issued an urgent ...

Prediction market platform Kalshi ⁠will ⁠start taking bets on ⁠the outcomes of clinical trials and FDA ​regulatory reviews, ...

At the beginning of July 2026, the U.S. Food and Drug Administration approved the first gene therapy for young children with ...

FDA sets PDUFA target action date of May 1, 2027NEW YORK, July 15, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a ...

Antiamyloid drugs clear amyloid plaques and modestly slow cognitive decline in patients with Alzheimer’s disease, but whether ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported financial results for the fourth quarter and ...

Detailed price information for Jupiter Neurosciences Inc (JUNS-Q) from The Globe and Mail including charting and trades.

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the fourth quarter and ...

Please provide your email address to receive an email when new articles are posted on . Several members of the Pharmacy Compounding Advisory Committee have industry connections or run pharmacies or ...